EMD-43795

Single-particle
3.6 Å
EMD-43795
3D View Gallery
Deposition: 23/02/2024
Map released: 06/11/2024
Last modified: 11/12/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-43795

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9arv summary report (pdf.gz) Map-9arv FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

CryoEM structure of AMETA-A3

EMD-43795

Single-particle
3.6 Å
EMD-43795
3D View Gallery
Deposition: 23/02/2024
Map released: 06/11/2024
Last modified: 11/12/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: Adaptive Multi-Epitope Targeting and Avidity-Enhanced (AMETA) Nanobody Platform
Fitted models: 9arv

Deposition Authors: Huang W, Sang Z, Taylor D
Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy.
Xiang Y , Xu J , McGovern BL, Ranzenigo A, Huang W, Sang Z, Shen J, Diaz-Tapia R, Pham ND, Teunissen AJP, Rodriguez ML, Benjamin J , Taylor DJ, van Leent MMT, White KM, Garcia-Sastre A, Zhang P, Shi Y
(2024) Cell , 187 , 6966 - 6980.e23
PUBMED: 39447570
DOI: doi:10.1016/j.cell.2024.09.043
ISSN: 1097-4172